Anucell Biosystems is a company focused on providing novel solurions to emerging difficlties in cell processing: mitigating the impacts of over-processing of primary cells for treatments including CAR-T therapies. We employ a proprietary technology to enable true bead-free enrichments of T-cells from PBMC or Leukopak inputs without need to add additional chemestries or exchange cells from their culture media. Enriched T-cells are functionally fit and ready for downstream processing with no requirement for bead removal or media exchange following enrichment.